Wisdomtree Issuer ICAV - Wisdomtree Biorevolution UCITS ETF (LON:WBIO)

Assets	31.26M
Expense Ratio	0.45%
PE Ratio	17.18
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+66.39%

Volume	2,860
Open	2,037.00
Previous Close	2,029.50
Day's Range	2,018.00 - 2,045.00
52-Week Low	1,201.40
52-Week High	2,045.00
Beta	0.72
Holdings	86
Inception Date	Dec 3, 2021

About WBIO

This WisdomTree BioRevolution UCITS ETF (the "Fund") aims to deliver investment results that mirror the price and income performance of the WisdomTree BioRevolution ESG Screened Index (the "Index"), prior to the deduction of any fees or expenses.

• Asset Class: Equity
• Category: Theme
• Stock Exchange: London Stock Exchange
• Ticker Symbol: WBIO
• Provider: WisdomTree
• Index Tracked: WisdomTree Battery Solutions Index

Performance

WBIO had a total return of 66.39% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.18%.

Top 10 Holdings

38.54% of assets

Name	Symbol	Weight
Twist Bioscience Corporation	TWST	8.69%
Moderna, Inc.	MRNA	8.23%
Eli Lilly and Company	LLY	3.54%
10x Genomics, Inc.	TXG	3.25%
Natera, Inc.	NTRA	2.84%
Johnson & Johnson	JNJ	2.82%
Tempus AI, Inc.	TEM	2.76%
Immunome, Inc.	IMNM	2.30%
Darling Ingredients Inc.	DAR	2.08%
United Therapeutics Corporation	UTHR	2.04%

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error